NewHavenBIZ

New Haven Biz-April 2021

Issue link: https://nebusinessmedia.uberflip.com/i/1357804

Contents of this Issue

Navigation

Page 4 of 31

n e w h a v e n b i z . c o m | A p r i l 2 0 2 1 | n e w h a v e n B I Z 5 A r o u n d t h e R e g i o n American Sentinel University delivers accredited online degree programs in nursing and healthcare management. Post University offers a variety of degree programs to students who wish to pursue education both in-person and online. Subway to move some departments to Miami e Subway restaurant chain recently indicated it plans to move some, but not all, of its Milford workforce to Miami. e company indicated that the majority of its corporate workforce will remain at its Milford headquarters, at 325 Sub Way. "Some functional areas are moving to Miami," Subway said. "ese include more consumer-facing positions in marketing, culinary and some global transformation roles. is enables the brand to establish even more seamless collaboration with our supply chain organization, the Indepen- dent Purchasing Cooperative, which is also based in Miami." FDA reprimands Biohaven over Kardashian migraine drug ad Biohaven Pharmaceuticals' hiring of a reality TV star to pitch its new migraine pill is stirring up some drama for the New Haven drug maker — in the form of a rebuke from the Food and Drug Administration. e regulatory agency took issue with a Biohaven-sponsored interview in which celebrity spokeswoman Khloe Kardashian heaps praise on the company's Nurtec ODT for changing her life as a longtime migraine sufferer. During the paid spot, which originally aired last July on the ABC talk show "e View," Kardashian hails the drug as a "game changer" that works better than other treatments she has tried and says it stops her headaches in as little as 15 minutes. e problem? None of those claims are supported by clinical trial data the FDA used to approve the drug, the agency's Office of Prescription Drug Promotion told Biohaven. e reprimand came in the form of an "untitled letter" — an FDA communication that stops short of a warning but alerts a company to a violation that needs to be corrected. According to Biohaven, it is working closely with the FDA to address its concerns. n 100 South Shore Drive, East Haven, CT 06512-4668 Tel: 203.468.8133 Fax: 203.469.8515 www.burzenski.com William S. Kalinowski, CPA, Managing Partner Email: bill@burzenski.com Services include: • Accounting • Tax Services • Financial Forecasts • Management Consulting • Business Valuation • Financial Planning • Bookkeeping Services • Wealth Management Your Trusted Resource For Financial Solutions Founded in 1983, Burzenski & Company, P.C. is an established leader in the accounting, tax and financial services fields. Our practice areas include businesses, individuals & families, veterinary medicine, construction companies, government entities, and more. Call us today for solutions you can trust. B R I E F S BY THE NUMBERS $200M The amount New Haven drug maker Biohaven Pharmaceuticals is seeking to raise in a secondary public offering. 1,200 The number of seasonal workers Lake Compounce in Bristol plans to hire for its 2021 summer season. 3% The percentage increase in Connecticut personal income in 2020, according to the Bureau of Economic Analysis, a unit of the U.S. Department of Commerce. 25% The percentage drop in new home permit activity in Connecticut during the first two months of 2021, compared with the same period a year ago. Post University PHOTO | CONTRIBUTED

Articles in this issue

Links on this page

Archives of this issue

view archives of NewHavenBIZ - New Haven Biz-April 2021